The Kaplan–Meier survival curves showed that the CCT2 expression levels were significantly associated with prognosis in ACC, BRCA, KICH, LICH, LUAD, MESO, OV, SARC, and THYM, where a high CCT2 expression was associated with poor prognosis in cancers other than OV (Figure 2B). Here, CCT2 is linked to thymoma.